These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3263872)

  • 1. Protective action of a calcium antagonist, nilvadipine, against aortic calcium deposition--a pathogenic factor in atherosclerosis.
    Mutoh S; Nomoto A; Sekiguchi C; Yamaguchi I
    Atherosclerosis; 1988 Oct; 73(2-3):181-9. PubMed ID: 3263872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.
    Koibuchi Y; Sakai S; Miura S; Ono T; Shibayama F; Ohtsuka M
    Atherosclerosis; 1989 Oct; 79(2-3):147-55. PubMed ID: 2597224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of nilvadipine against glutamate neurotoxicity in purified retinal ganglion cells.
    Otori Y; Kusaka S; Kawasaki A; Morimura H; Miki A; Tano Y
    Brain Res; 2003 Jan; 961(2):213-9. PubMed ID: 12531488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New dihydropyridine drug, nilvadipine, blocks the calcium slow action potential in rat-cultured aortic smooth muscle cells.
    Bkaily G; Molyvdas PA; Ousterhout J; Sperelakis N
    Eur J Pharmacol; 1986 May; 124(1-2):59-65. PubMed ID: 3720845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged inhibitory effects of nilvadipine (FR34235) following washout in isolated rabbit aorta and mesenteric artery.
    Furuta T
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):134-8. PubMed ID: 2452305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonist. Effect on cuff-induced intimal thickening of rabbit carotid artery.
    Nomoto A; Hirosumi J; Sekiguchi C; Mutoh S; Yamaguchi I; Aoki H
    Atherosclerosis; 1987 Apr; 64(2-3):255-61. PubMed ID: 3606723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of two calcium channel blockers--nifedipine and diltiazem--on atherogenesis in hypercholesterolemic hamster.
    Raicu M; Pojoga L; Simionescu N; Simionescu M
    J Submicrosc Cytol Pathol; 1996 Apr; 28(2):265-75. PubMed ID: 8964051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of benidipine hydrochloride (KW-3049), a calcium antagonist, against experimental arterial calcinosis and endothelial dysfunction in rats.
    Higo K; Karasawa A; Kubo K
    J Pharmacobiodyn; 1992 Mar; 15(3):113-20. PubMed ID: 1625168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S; Li Y; Shirasawa M; Yasui N; Fukasawa H
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
    Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
    Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nilvadipine inhibits acute rise of aqueous flare and intraocular pressure induced by prostaglandin E2 in pigmented rabbits.
    Zhang XY; Hiraki S; Hayasaka S
    Ophthalmic Res; 1998; 30(3):135-41. PubMed ID: 9618717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by nilvadipine of ischemic and carrageenan paw edema as well as of superoxide radical production from neutrophils and xanthine oxidase.
    Oyanagui Y; Sato S
    Arzneimittelforschung; 1991 May; 41(5):469-74. PubMed ID: 1654907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of drug effects of calcium channel blockers on retinal degeneration of rd mouse.
    Takano Y; Ohguro H; Dezawa M; Ishikawa H; Yamazaki H; Ohguro I; Mamiya K; Metoki T; Ishikawa F; Nakazawa M
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1015-22. PubMed ID: 14706644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine.
    Nomoto A; Mutoh S; Hagihara H; Yamaguchi I
    Atherosclerosis; 1988 Aug; 72(2-3):213-9. PubMed ID: 2850808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nilvadipine as a neuroprotective calcium entry blocker in a rat model of global cerebral ischemia. A comparative study with nicardipine hydrochloride.
    Takakura S; Sogabe K; Satoh H; Mori J; Fujiwara T; Totsuka Z; Tokuma Y; Kohsaka M
    Neurosci Lett; 1992 Jul; 141(2):199-202. PubMed ID: 1436634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nilvadipine on adrenocortical cell proliferation and steroidogenesis in early stage of adrenal regeneration.
    Zieleniewski W
    Exp Toxicol Pathol; 1993 Aug; 45(4):245-7. PubMed ID: 8219715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nilvadipine, nicardipine and verapamil on acute rise of aqueous flare induced by iris photocoagulation or intravenous lipopolysaccharides in pigmented rabbits.
    Zhang XY; Hiraki S; Kadoi C; Hayasaka S
    Ophthalmic Res; 2000; 32(5):205-9. PubMed ID: 10971181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.